Citronellal ameliorates doxorubicin‐induced hepatotoxicity via antioxidative stress, antiapoptosis, and proangiogenesis in rats
Xu Liu,Yue Qiu,Yanhua Liu,Ning Huang,Cai Hua,Qianqian Wang,Zeqing Wu,Junxiu Lu,Ping Song,Jian Xu,Peng Li,Yaling Yin
DOI: https://doi.org/10.1002/jbt.22639
IF: 3.568
2020-10-13
Journal of Biochemical and Molecular Toxicology
Abstract:<p>Doxorubicin (DOX) is a very effective broad‐spectrum anticancer drug, yet its clinical application is badly restricted due to its serious side effects. Citronellal (CT), a specialized metabolite of plants found in <i>Cymbopogon</i> spp., is proved to exhibit many beneficial properties. In the current study, we intended to investigate the effect of CT on DOX‐induced hepatotoxicity in rats. Rats were treated with CT (200 mg/kg b.w./day orally), and given DOX (2.5 mg/kg b.w./week, intraperitoneally) to induce hepatotoxicity for six consecutive weeks. The results showed that CT administration could attenuate the DOX‐induced pathological changes of liver tissues and ameliorated the inappropriate alteration of liver function biomarkers (serum glutamic aspartate aminotransferase, glutamic pyruvic transaminase, and albumin) in serum and oxidative stress parameters (malondialdehyde, superoxide dismutase, and reduced glutathione) in the liver. Moreover, CT mitigated the Bax/Bcl‐2 ratio and caspase‐3 expression to inhibit cell apoptosis. Further study indicated that CT therapy could enhance the protein levels of p‐PI3K, p‐Akt, and CD31 in the liver. These results demonstrate that CT can ameliorate DOX‐induced hepatotoxicity in rats mediated by antioxidative stress, antiapoptosis, and proangiogenesis.</p>
biochemistry & molecular biology,toxicology